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In the fungus world, just as in the
business one, the key to success is flexibility.
A fungus that can adapt and change to its
environment is positioned to leap into new
opportunities ahead of the competition.
If this is true, then Candida albicans is the
Starbucks of fungi. C. albicans is a small,
mobile fungus present in all of us, usually in
the gastrointestinal tract or the mucus
membrane. Most fungi exist in one of two
forms—hypha or yeast. However, unlike
most fungi, C. albicans can freely switch
between hypha and yeast in a matter of
hours, triggered by environmental changes
like temperature or cell density. In the yeast
form, it is not terribly dangerous but is
highlymobile,hitchingaride inbloodflows
or other body processes. The hypha form
spreads faster, given its filamentous-like
nature, but cannot, for example, move into
the bloodstream, and its ill-effects are
limited. This phenomenon, called dimor-
phism, allows the fungus to quickly take
advantage of changes and quickly adapt
before its neighbors. Scientists have long
struggled to understand the mechanisms
that allow C. albicans to quickly slip between
hypha and yeast phase. This week in PLoS
Biology, a team of researchers from the
University of California Irvine led by
Haoping Liu provide a crucial new model
for understanding the phenomenon.
In most people, C. albicans is just another
member of the body’s flora, harmlessly
coexisting with other microorganisms in
their host. Bacteria in particular are
important competitors that keep its spread
in check. However, if the environment
suddenly changes, causing bacteria to die
off, C. albicans quickly adapts and takes
over. Usually the effects are minor. Elderly
people who use dentures may experience a
dry or burning mouth condition known as
‘‘thrush.’’ Women who suffer from irritat-
ing yeast infections and most babies
fussing over diaper rash are the victims
of an overaggressive population of C.
albicans. However, if the patient’s white
blood cells have been compromised, say
because of chemotherapy or an aggressive
steroid treatment, the effects can be
devastating. Serious complications arise if
the fungus enters the bloodstream, per-
haps through a catheter, which C. albicans
can only do while in the more benign yeast
form. However, once in the bloodstream,
the fungus can deposit throughout the
body as invasive hyphae. At that point it
becomes known as ‘‘hematogenously dis-
seminated candidiasis,’’ which proves fatal
in 40% of cases, even with the best
modern treatments.
The key to C. albicans’ success is that it is
highly adapted to change, switching be-
tween forms several times while its micro-
bial neighbors must remain either one or
the other. Sometimes the fungi will even
switch as self-defense, using hyphal struc-
tures to fend off attackers. As a result,
scientists have long tried to understand the
mechanisms that allow C. albicans to
quickly slip between hypha and yeast
phase. A team at the University of
California Irvine has painstakingly nar-
rowed down the process to a series of two
sequential genetic triggers that give this
fungus its unique advantage.
First, they found that the primary obstacle
to a swift yeast-hypha switch is a protein that
inhibits transcription called Nrg1. The team
found that before C. albicans transitions into
the hyphal stage, it expunges Nrg1 by
activating a major growth signaling pathway
called cAMP-PKA.
After the Nrg1 was evacuated, the cell
began to change its shape as well as its
transcriptional program. But in order to
prevent Nrg1 from returning to its position
on the DNA—and keep the transition
process moving without interruption—
another protein, called Hda1, was recruit-
ed to maintain transcription and prevent
the Nrg1 from binding to DNA. Hda1
achieved this by modifying, or deacetylat-
ing, the histone proteins that wrap around
the DNA.
The authors demonstrate this model by
creating mutant strains of C. albicans that
could not produce Hda1 and thus were
unable to complete the transition to the
hyphal stage, despite the conditions being
otherwiseperfect (manythingscaninducea
change, but the team used the most
reliable—raising the temperature to 37uC
and mixing in blood serum). The team also
found that for a successful transition to
hyphae, the yeast required rich, nutrient-
packed media and that in nutrient-poor
media, the hyphae simply stayed hyphae.
Liu and her team have created a new
framework to look at dimorphism. Their
results shed light on a mysterious process
that is a major factor in lethal hospital
infections. It also may aid in finding new
treatments for diseases related to C. albicans
if scientists could find a way to trap the
fungus in its yeast form. It’s also possible,
now that scientists understand how the
mechanism works, that they’ll find out that
many other animals use similar tools to
perform a variety of tasks.
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New research supports a new model to
explain how C. albicans, the most com-
mon cause of invasive fungal infections
in humans, manages the morphological
plasticity necessary for pathogenesis.
doi:10.1371/journal.pbio.1001108.g001
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